Filter Articles
Pfizer-BioNTech COVID-19 Vaccine for children ages 5 through 11 years
On October 29, 2021, the U.S. Food and Drug Administration authorized the emergency use of…
Third dose of Vaccination for Immune Suppressed Patients
Third dose of Vaccination for Immune Suppressed Patients August 19, 2021 A statement from our…
FDA Warning for Guillain–Barre Syndrome and the Johnson & Johnson COVID-19 Vaccine
A Statement from the Foundation Global Medical Advisory Board The Washington Post and New York…
Statement on Vaccines and GBS
Statement on Vaccines and GBS June 18, 2021 There is no evidence at the present…
Ask The Experts Episode 9 – COVID-19 Vaccines and the GBS|CIDP Community
Ask The Experts Episode 9 – COVID-19 Vaccines and the GBS|CIDP CommunityFeaturing Dr. Peter Donofrio,…
COVID-19 Vaccines and the GBS|CIDP Community
Rate of Recurrent Guillain-Barré Syndrome After mRNA COVID-19 Vaccine BNT162b2, (Jama Neurology) September 1st, 2021…
Foundation Global Medical Advisory Board statement on COVID vaccines for CIDP and MMN
No instances of CIDP or MMN were seen during clinical trials of the two vaccines.…
Dr. A.S. Fauci Corrects Previous Statement Regarding COVID-19 Vaccines & GBS
As a follow up to the Foundation’s published article from Dec. 20, 2020, “An Open…
Persons who have previously had GBS may receive an mRNA COVID-19 vaccine
Adults of any age with certain underlying medical conditions are at increased risk for severe illness from the…
Statement from Professor Lunn in Reference to Newest Research on COVID-19, GBS, and Vaccines
In reaction to recent research published in Brain (click here to read more), Professor Lunn…
New Study Reveals No Association Between COVID-19 and Guillain-Barré Syndrome
The GBS|CIDP Foundation is committed to sharing the most accurate information from the world’s leading…
Covid19, Ask the Expert
Virtual Ask the Experts Series April 22, 2020 - Dr. Ken Gorson Part of our virtual…
Grifols Announces Formal Collaboration with US Government to Produce the First Treatment Specifically Targeting COVID-19
Grifols Announces Formal Collaboration with US Government to Produce the First Treatment Specifically Targeting COVID-19
What is Convalescent Plasma?
By Dr. David Saperstein Antibodies (also known as immunoglobulins) play an important role in health…
Resource from PPTA Regarding COVID-19
The Plasma Protein Therapeutics Association (PPTA) has provided a statement specific to plasma protein therapies…